Overexpression of p53 Protein During Pancreatitis
Author Information
Author(s): H Maacke, A Kessler, W Schmiegel, C Roeder, I Vogel, W Deppert, H Kalthoff
Primary Institution: Heinrich-Pette-Institut fur Experimentelle Immunologie und Virologie, Universitat Hamburg
Hypothesis
Is overexpressed p53 a useful tumor marker for detecting pancreatic cancer in patients with pancreatitis?
Conclusion
The assessment of p53 protein overexpression is not useful in the diagnosis of pancreatic cancer.
Supporting Evidence
- 59% of patients with pancreatitis showed p53 overexpression.
- 67% of patients with pancreatic carcinoma showed p53 overexpression.
- Apoptotic cell death was observed in all tested specimens from patients with pancreatitis.
Takeaway
Doctors looked at samples from patients with pancreatitis and pancreatic cancer to see if a protein called p53 could help find pancreatic cancer, but it didn't work.
Methodology
Cytological specimens of pancreatic juice samples were analyzed for p53 protein overexpression using immunocytochemistry.
Limitations
Not all patients' samples could be tested with the entire panel of antibodies due to limitations in specimen yield.
Participant Demographics
27 patients with chronic pancreatitis and 15 patients with pancreatic ductal adenocarcinomas.
Want to read the original?
Access the complete publication on the publisher's website